ALSO READ

Ozone Ayurvedics, the FMCG arm of Ozone group of companies, is eyeing a turnover of Rs 200 crore next fiscal, up from Rs 120 crore right now, on the back of new tailor-made skincare products and marketing thrust.

The company will invest Rs 50 crore in research and product development.

"We are hopeful of almost doubling our turnover to Rs 200 crore this fiscal," said SC Sehgal, chairman of the company.

Ozone, maker of No Marks, an anti-marks cream, plans to cash in on market segmentation strategy to boost sales. So, for instance, it has launched three variants of No-Marks for different age groups, and hopes to achieve sales of Rs 8 crore every month post the launch. No-Marks currently is a Rs 40 crore brand. “We are entering specialised areas in skincare products and building on differentiation strategy to boost sales,” Sehgal said. “We are also looking at launching several new products in the affordable range, priced between Rs 10 and Rs 70,” Sehgal added.

The company also plans to increase its exports to UAE and UK, among other countries. Currently, it earns around Rs 10 crore from exports.

The company has six plants--three each in Himachal Pradesh and Assam. It has an organic farming facility in Haryana as well. "We have recently acquired 65 acres in Assam for organic cultivation," said Sehgal.

The company, with over a decade's presence in research and development of herbal and ayurvedic products, is planning to launch oil-free sunscreen lotion, No Marks anti-acne face cream, anti-acne face pack and anti-acne scrub in the therapeutic segment.

It also has plans to launch No Pimple No Mark face washes and soaps in the preventive segment. “Currently East India contributes 22 per cent and West Bengal nearly 7.5 per cent to the overall sales of Nomarks brand, which we propose to increase to at least four times in the next few months”, said Sehgal.

Ozone Ayurvedics announced its association with cop Kiran Bedi to endorse its flagship product Nomarks skincare cream. Associating with Bedi is part of the company’s plan to restage the brand and extend it beyond the anti-marks proposition to a daily use skin cream, Sehgal said.